KNSA
#907
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
78.5 1 USD
0.00%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-0.15%
Monthly Change
+6.25%
6 month change
+77.46%
Year Change
+98.03%
Previous Close
78.6 3
Open
78.3 9
Low
78.3 9
High
78.7 0
Volume
101
Financials
- Market Capitalization 9.99 B
- Employee 366
- Founded 2015
- CEO N/A
- Website www.kiniksa.com
- Headquarter N/A
- FIGI N/A
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
65.26
Price to sales ratio
—
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 874 |  KRYS Krystal Biotech, Inc. - Common Stock | 360.05 USD | +0.19% | +1.12% | +12.27% | +92.41% | 10.66 B USD | ||
| 904 |  IONS Ionis Pharmaceuticals, Inc. - Common Stock | 60.38 USD | +0.03% | -5.35% | +14.66% | -16.28% | 10.03 B USD | ||
| 908 |  CYTK Cytokinetics, Incorporated - Common Stock | 71.78 USD | +1.23% | -8.26% | -6.40% | +23.55% | 9.98 B USD | ||
| 919 |  KYMR Kymera Therapeutics, Inc. - Common Stock | 117.77 USD | -0.88% | -7.62% | +14.60% | +99.27% | 9.79 B USD |
Frequently asked questions about Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares
What is the Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares stock price today?
The current price of Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares (KNSA) is 78.51. Over the past 24 hours, the stock has changed by -0.15%. Follow the KNSA chart for real-time price dynamics.
What is the stock ticker of Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares?
Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares trades under the ticker KNSA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares stock going up?
KNSA has changed by -1.78% over the last week, +6.25% over the last month, and +98.03% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares?
Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares currently has a market capitalization of 9.99 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares earnings last quarter?
Last quarter, Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares reported earnings of 0.33 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares revenue for the last quarter?
Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares reported quarterly revenue of 243.6 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares net income for the last quarter?
Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares reported net income of 25.43 M for the last quarter. The previous quarter showed 22.59 M, which means net income changed by +12.57%.
How many employees does Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares have?
As of the latest available data, Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares has 366 employees. Workforce size can provide additional context about the company's scale and operations.
What is Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares EBITDA?
Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares EBITDA is 115.43 M, and its EBITDA margin is 47.38%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares stock?
You can buy Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares (KNSA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares stock?
Investing in Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the KNSA chart and related analysis on metatrader.com as part of your research.